Moolec Science S.A.
Moolec Science S.A.
Your view on MLECW
Overview
What the company does, where it operates, and who runs it.
About Moolec Science S.A.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alejandro Antalich
- Headquarters
- 89 Nexus Way, Grand Cayman, GT, KY
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alejandro Antalich
- Headquarters
- 89 Nexus Way, Grand Cayman, GT, KY
Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector.
The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Moolec Science S.A. from FRC's valuation model, read against the market price. MLECW last traded at $0.0070; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Moolec Science S.A.. Starting points for Moolec Science S.A.: EPS -$17.25, beta 0.09 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Moolec Science S.A.. Moolec Science S.A. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Moolec Science S.A.. Trailing twelve-month EPS for Moolec Science S.A. stands at -$17.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings Estimate
| EPS | Current QtrMar 2025 | Next QtrJun 2025 | Current YearFY Jun 2026 | Next YearFY Jun 2027 |
|---|---|---|---|---|
| Avg. estimate | -$9.00 | -$10.50 | -$36.00 | $6.00 |
| Low estimate | -$9.00 | -$10.50 | -$36.00 | $6.00 |
| High estimate | -$9.00 | -$10.50 | -$36.00 | $6.00 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | -$0.04 | -$0.07 | -$17.25 | — |
| Growth | -24158.8% | -15809.1% | -108.7% | — |
Revenue Estimate
| Revenue | Current QtrMar 2025 | Next QtrJun 2025 | Current YearFY Jun 2026 | Next YearFY Jun 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.01M | $2.01M | $8.63M | $77.33M |
| Low estimate | $2.01M | $2.01M | $8.63M | $77.33M |
| High estimate | $2.01M | $2.01M | $8.63M | $77.33M |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | $2.11M | $1.52M | $333.61M | — |
| Growth | -4.9% | +32.0% | -97.4% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 13, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Moolec Science S.A.. Moolec Science S.A. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Moolec Science S.A. valued side by side against its closest peers. Moolec Science S.A. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Moolec Science S.A.. Coverage tracks Moolec Science S.A. within Biotechnology (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Moolec Science S.A.